3Q PREVIEW: Bristol-Myers, Lilly ask investors to look ahead
This article was originally published in Scrip
Executive Summary
When they announce third-quarter earnings this week, Bristol-Myers Squibb and Eli Lilly will ask their investors for continued patience as the two companies continue to lay the groundwork for future growth.